An observational study of direct oral anticoagulant awareness indicating inadequate recognition with potential for patient harm. | AHRQ Patient Safety Network

An observational study of direct oral anticoagulant awareness indicating inadequate recognition with potential for patient harm. | AHRQ Patient Safety Network

• Study
 
• Published February 2016

An observational study of direct oral anticoagulant awareness indicating inadequate recognition with potential for patient harm.

Olaiya A, Lurie B, Watt B, McDonald L, Greaves M, Watson HG. J Thromb Haemost. 2016 Feb 10; [Epub ahead of print].

Anticoagulant medications are known to be high-risk for adverse drug events. This study found that many physicians fail to recognize risks associated with direct oral anticoagulants or their effect on anticoagulation tests. These results raise concern for patient harm due to insufficient knowledge about these medications.

PubMed citationAvailable at

Related Resources

JOURNAL ARTICLE › COMMENTARY

Direct oral anticoagulants: new drugs with practical problems. How can nurses help prevent patient harm?

Barras MA, Hughes D, Ullner M. Nurs Health Sci. 2016 Feb 2; [Epub ahead of print].

JOURNAL ARTICLE › REVIEW

Predictors of warfarin-associated adverse events in hospitalized patients: opportunities to prevent patient harm.

Metersky ML, Eldridge N, Wang Y, et al. J Hosp Med. 2016;11:276-282.

JOURNAL ARTICLE › STUDY

Improving transitions of care for patients on warfarin: the Safe Transitions Anticoagulation Report.

Dunn AS, Shetreat-Klein A, Berman J, et al. J Hosp Med. 2015;10:615-618.

NEWSPAPER/MAGAZINE ARTICLE

Popular blood thinner causing deaths, injuries in nursing homes.

Ornstein C. Washington Post. July 12, 2015.

PRESS RELEASE/ANNOUNCEMENT

Heparin-containing medical devices and combination products: recommendations for labeling and safety testing. Draft guidance for industry and Food and Drug Administration staff.

Federal Register. Washington, DC: US Department of Health and Human Services. Baltimore, MD: Food and Drug Administration. July 9, 2015;80:39440-39441.

View More